Literatur (Auswahl)

A Patient Charter to Improve Care for Hepatocellular Carcinoma.

Hassan Y, Kautz A, James C, Lee D, Langenbacher D, Bouffet E, Chakowa J, Hicks J, Ward JW, Kuschnereit LA, Allaire M, Zhang T, Huang Chi Z. J Hepatocell Carcinoma. 2025 Aug 20;12:1849-1859. doi: 10.2147/JHC.S526170. eCollection 2025. PMID: 40861312 Free PMC article. Review.

 

Prioritising viral hepatitis elimination to prevent hepatocellular carcinoma: A public health approach for effective preventive hepatology.

Ivancovsky Wajcman D, Nicolàs A, Picchio CA, van Selm L, Dusheiko G, Younossi ZM, Dillon JF, Alqahtani SA, Razavi H, Colombo MG, Kautz A, Dore GJ, Lazarus JV. JHEP Rep. 2025 May 2;7(8):101436. doi: 10.1016/j.jhepr.2025.101436. eCollection 2025 Aug. PMID: 40677690 Free PMC article. Review.

 

Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis.

Younossi ZM, Zelber-Sagi S, Lazarus JV, Wong VW, Yilmaz Y, Duseja A, Eguchi Y, Castera L, Pessoa MG, Oliveira CP, El-Kassas M, Tsochatzis E, Fan JG, Spearman CW, Tacke F, Castellanos Fernandez MI, Alkhouri N, Schattenberg JM, Romero-Gómez M, Noureddin M, Allen AM, Ong JP, Roberts SK, Shubrook JH, Burra P, Kohli R, Kautz A, Holleboom AG, Lam B, Isaacs S, Macedo P, Gastaldelli A, Henry L, Ivancovsky-Wajcman D, Nader F, de Avila L, Price JK, Mark HE, Villota-Rivas M, Barberá A, Kalligeros M, Gerber LH, Alqahtani SA. Gastroenterology. 2025 Oct;169(5):1017-1032.e2. doi: 10.1053/j.gastro.2025.02.044. Epub 2025 Apr 11. PMID: 40222485 Free article.

 

Symptom Reporting in Patients with Primary Biliary Cholangitis: Higher Burden of Symptom Detection Using an Interactive App.

Daza J, Espinosa-Montagut N, Kautz A, Langenbacher D, Hetjens M, Siegel F, Ebert MP, Teufel A. Dig Dis. 2025;43(2):170-178. doi: 10.1159/000543229. Epub 2025 Jan 14. PMID: 39809233

 

Sub-optimal therapy of patients with primary biliary cholangitis (PBC) in the real-life stetting of the German PBC cohort.

Wiegand J, Franke A, Müller T, Stein K, Bantel H, Günther R, Denk G, Reuken PA, Schattenberg JM, Naumann U, Böttler T, Weber A, Zeuzem S, Hinz M, Greinert R, Berg C, Wissniowski TT, Simon KG, Trebicka J, Behrens R, Grümmer H, Hofmann WP, Dikopoulos N, Sarrazin C, Roeb E, Kremer AE, Muche M, Ringelhan M, Teufel A, Michl P, Keitel V, Marquardt JU, Kautz A, Tacke F, Piotrowski K, Köppe-Bauernfeind N, Trautwein C, Berg T. Z Gastroenterol. 2024 Nov;62(11):1931-1942. doi: 10.1055/a-2382-7720. Epub 2024 Sep 3. PMID: 39227008 English.

 

The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease.

Younossi ZM, AlQahtani SA, Funuyet-Salas J, Romero-Gómez M, Yilmaz Y, Keklikkiran C, Alswat K, Yu ML, Liu CJ, Fan JG, Zheng MH, Burra P, Francque SM, Castera L, Schattenberg JM, Newsome PN, Allen AM, El-Kassas M, Treeprasertsuk S, Hameed S, Wai-Sun Wong V, Zelber-Sagi S, Takahashi H, Kawaguchi T, Castellanos Fernández MI, Duseja A, Arrese M, Rinella M, Singal AK, Gordon SC, Fuchs M, Eskridge W, Alkhouri N, Cusi K, Loomba R, Ranagan J, Kautz A, Ong JP, Kugelmas M, Eguchi Y, Diago M, Gerber L, Lam B, Fornaresio L, Nader F, Spearman CW, Roberts SK, Chan WK, Silva M, Racila A, Golabi P, Ananchuensook P, Henry L, Stepanova M, Carrieri P, Lazarus JV; Global NASH Council. JHEP Rep. 2024 Mar 12;6(7):101066. doi: 10.1016/j.jhepr.2024.101066. eCollection 2024 Jul. PMID: 39022387 Free PMC article.

 

Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.

Younossi ZM, Alqahtani SA, Alswat K, Yilmaz Y, Keklikkiran C, Funuyet-Salas J, Romero-Gómez M, Fan JG, Zheng MH, El-Kassas M, Castera L, Liu CJ, Wai-Sun Wong V, Zelber-Sagi S, Allen AM, Lam B, Treeprasertsuk S, Hameed S, Takahashi H, Kawaguchi T, Schattenberg JM, Duseja A, Newsome PN, Francque S, Spearman CW, Castellanos Fernández MI, Burra P, Roberts SK, Chan WK, Arrese M, Silva M, Rinella M, Singal AK, Gordon S, Fuchs M, Alkhouri N, Cusi K, Loomba R, Ranagan J, Eskridge W, Kautz A, Ong JP, Kugelmas M, Eguchi Y, Diago M, Yu ML, Gerber L, Fornaresio L, Nader F, Henry L, Racila A, Golabi P, Stepanova M, Carrieri P, Lazarus JV; Global NASH Council. J Hepatol. 2024 Mar;80(3):419-430. doi: 10.1016/j.jhep.2023.11.004. Epub 2023 Nov 18. PMID: 37984709

 

A global action agenda for turning the tide on fatty liver disease.

Lazarus JV, Mark HE, Allen AM, Arab JP, Carrieri P, Noureddin M, Alazawi W, Alkhouri N, Alqahtani SA, Anstee QM, Arrese M, Bataller R, Berg T, Brennan PN, Burra P, Castro-Narro GE, Cortez-Pinto H, Cusi K, Dedes N, Duseja A, Francque SM, Gastaldelli A, Hagström H, Huang TTK, Ivancovsky Wajcman D, Kautz A, Kopka CJ, Krag A, Newsome PN, Rinella ME, Romero D, Sarin SK, Silva M, Spearman CW, Terrault NA, Tsochatzis EA, Valenti L, Villota-Rivas M, Zelber-Sagi S, Schattenberg JM, Wong VW, Younossi ZM; on behalf of the Healthy Livers, Healthy Lives Collaborators. Hepatology. 2024 Feb 1;79(2):502-523. doi: 10.1097/HEP.0000000000000545. Epub 2023 Aug 4. PMID: 37540183 Free PMC article.

 

Lifestyle interventions for patients with non-alcoholic steato-hepatitis-Design, rationale and protocol of the study "target group-specific optimisation of lifestyle interventions for behavior change in non-alcoholic steato-hepatitis (OPTI-NASH)".

Krüger K, Oedingen C, Kautz A, Langenbacher D, Rossol S, Stahmeyer JT, Krauth C. PLoS One. 2023 Jul 27;18(7):e0288905. doi: 10.1371/journal.pone.0288905. eCollection 2023. PMID: 37498941 Free PMC article.

A global research priority agenda to advance public health responses to fatty liver disease.

Lazarus JV, Mark HE, Allen AM, Arab JP, Carrieri P, Noureddin M, Alazawi W, Alkhouri N, Alqahtani SA, Arrese M, Bataller R, Berg T, Brennan PN, Burra P, Castro-Narro GE, Cortez-Pinto H, Cusi K, Dedes N, Duseja A, Francque SM, Hagström H, Huang TT, Wajcman DI, Kautz A, Kopka CJ, Krag A, Miller V, Newsome PN, Rinella ME, Romero D, Sarin SK, Silva M, Spearman CW, Tsochatzis EA, Valenti L, Villota-Rivas M, Zelber-Sagi S, Schattenberg JM, Wong VW, Younossi ZM; Healthy Livers, Healthy Lives Collaborators. J Hepatol. 2023 Sep;79(3):618-634. doi: 10.1016/j.jhep.2023.04.035. Epub 2023 Jun 20. PMID: 37353401 Free article.

 

S3-Leitlinie Diagnostik und Therapie biliärer Karzinome.

Bitzer M, Groß S, Albert J, Boda-Heggemann J, Brunner T, Caspari R, De Toni E, Dombrowski F, Evert M, Geier A, Gkika E, Götz M, Helmberger T, Hoffmann RT, Huppert P, Kautz A, Krug D, Fougère C, Lang H, Lenz P, Lüdde T, Mahnken A, Nadalin S, Nguyen HHP, Ockenga J, Oldhafer K, Paprottka P, Pereira P, Persigehl T, Plentz R, Pohl J, Recken H, Reimer P, Riemer J, Ritterbusch U, Roeb E, Rüssel J, Schellhaas B, Schirmacher P, Schlitt HJ, Schmid I, Schuler A, Seehofer D, Sinn M, Stengel A, Stoll C, Tannapfel A, Taubert A, Tholen R, Trojan J, van Thiel I, Vogel A, Vogl T, Wacker F, Waidmann O, Wedemeyer H, Wege H, Wildner D, Wörns MA, Galle P, Malek N. Z Gastroenterol. 2023 Apr;61(4):420-440. doi: 10.1055/a-2026-1277. Epub 2023 Apr 11. PMID: 37040777 Free article. German. No abstract available.

 

[Intersectoral management of patients with abnormal liver enzymes and non-alcoholic fatty liver disease (NAFLD)].

Teufel A, Geier A, Sarrazin C, Schattenberg JM, Kautz A, Dorner R, Kramer J, Jerysiak K, Baars T, Hönscheid B, Müller-Wieland D, Rossol S, Trautwein C, Tacke F, Canbay A. Z Gastroenterol. 2023 Aug;61(8):1028-1036. doi: 10.1055/a-1957-5671. Epub 2023 Feb 15. PMID: 36791784 Free PMC article. German.

 

Updated epidemiology of hepatitis C virus infections and implications for hepatitis C virus elimination in Germany.

Tergast TL, Blach S, Tacke F, Berg T, Cornberg M, Kautz A, Manns M, Razavi H, Sarrazin C, Serfert Y, van Thiel I, Zeuzem S, Wedemeyer H. J Viral Hepat. 2022 Jul;29(7):536-542. doi: 10.1111/jvh.13680. Epub 2022 May 5. PMID: 35357770

 

Advancing the global public health agenda for NAFLD: a consensus statement.

Lazarus JV, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, Cortez-Pinto H, Crespo J, Cusi K, Dirac MA, Francque S, George J, Hagström H, Huang TT, Ismail MH, Kautz A, Sarin SK, Loomba R, Miller V, Newsome PN, Ninburg M, Ocama P, Ratziu V, Rinella M, Romero D, Romero-Gómez M, Schattenberg JM, Tsochatzis EA, Valenti L, Wong VW, Yilmaz Y, Younossi ZM, Zelber-Sagi S; NAFLD Consensus Consortium. Nat Rev Gastroenterol Hepatol. 2022 Jan;19(1):60-78. doi: 10.1038/s41575-021-00523-4. Epub 2021 Oct 27. PMID: 34707258 Free article. Review.

 

Non-alcoholic fatty liver disease: A patient guideline.

Francque SM, Marchesini G, Kautz A, Walmsley M, Dorner R, Lazarus JV, Zelber-Sagi S, Hallsworth K, Busetto L, Frühbeck G, Dicker D, Woodward E, Korenjak M, Willemse J, Koek GH, Vinker S, Ungan M, Mendive JM, Lionis C. JHEP Rep. 2021 Sep 17;3(5):100322. doi: 10.1016/j.jhepr.2021.100322. eCollection 2021 Oct. PMID: 34693236 Free PMC article.

 

Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis.

Schattenberg JM, Lazarus JV, Newsome PN, Serfaty L, Aghemo A, Augustin S, Tsochatzis E, de Ledinghen V, Bugianesi E, Romero-Gomez M, Bantel H, Ryder SD, Boursier J, Leroy V, Crespo J, Castera L, Floros L, Atella V, Mestre-Ferrandiz J, Elliott R, Kautz A, Morgan A, Sansom SL, Vasudevan S, Pezzullo L, Trylesinski A, Cure S, Higgins V, Ratziu V. Liver Int. 2021 Jun;41(6):1227-1242. doi: 10.1111/liv.14825. Epub 2021 Mar 18. PMID: 33590598 Free PMC article. Review.

 

Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitis.

Cook N, Geier A, Schmid A, Hirschfield G, Kautz A, Schattenberg JM, Balp MM. JHEP Rep. 2020 Feb 1;2(2):100081. doi: 10.1016/j.jhepr.2020.100081. eCollection 2020 Apr. PMID: 32190823 Free PMC article.

 

Self-testing for liver disease - response to an online liver test questionnaire.

Kautz A, Dorner R, Antoni C, Ebert M, Teufel A. Scand J Gastroenterol. 2020 Jan;55(1):67-73. doi: 10.1080/00365521.2019.1699600. Epub 2019 Dec 10. PMID: 31822163

 

Elimination of hepatitis C virus in Germany: modelling the cost-effectiveness of HCV screening strategies.

Krauth C, Rossol S, Ortsäter G, Kautz A, Krüger K, Herder B, Stahmeyer JT. BMC Infect Dis. 2019 Dec 2;19(1):1019. doi: 10.1186/s12879-019-4524-z. PMID: 31791253 Free PMC article.

 

The Patient Perspectives on Future Therapeutic Options in NASH and Patient Needs.

Cook N, Geier A, Schmid A, Hirschfield G, Kautz A, Schattenberg JM, Balp MM. Front Med (Lausanne). 2019 Apr 3;6:61. doi: 10.3389/fmed.2019.00061. eCollection 2019. PMID: 31106203 Free PMC article.

 

Recommendations for the management of hepatitis C virus infection among people who inject drugs.

Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ; International Network for Hepatitis in Substance Users. Int J Drug Policy. 2015 Oct;26(10):1028-38. doi: 10.1016/j.drugpo.2015.07.005. Epub 2015 Jul 17. PMID: 26282715 Free PMC article.

 

Improved hepatitis C screening and treatment in people who inject drugs should be a priority in Europe.

Kautz A, Chavdarova L, Walker M. BMC Infect Dis. 2014;14 Suppl 6(Suppl 6):S3. doi: 10.1186/1471-2334-14-S6-S3. Epub 2014 Sep 19. PMID: 25253094 Free PMC article. No abstract available.

 

Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement.

Schaefer M, Capuron L, Friebe A, Diez-Quevedo C, Robaeys G, Neri S, Foster GR, Kautz A, Forton D, Pariante CM. J Hepatol. 2012 Dec;57(6):1379-90. doi: 10.1016/j.jhep.2012.07.037. Epub 2012 Aug 7. PMID: 22878466